Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1996-01

AUTHORS

H Modjtahedi, T Hickish, M Nicolson, J Moore, J Styles, S Eccles, E Jackson, J Salter, J Sloane, L Spencer, K Priest, I Smith, C Dean, M Gore

ABSTRACT

The purpose of this study was to determine the effect of the first rat monoclonal antibody (MAb ICR62) to the epidermal growth factor receptor (EGFR) in a phase I clinical trial in patients with unresectable squamous cell carcinomas. This antibody effectively blocks the binding of EGF, transforming growth factor (TGF)-alpha and HB-EGF to the EGFR, inhibits the growth in vitro of tumour cell lines which overexpress the EGFR and eradicates such tumours when grown as xenografts in athymic mice. Eleven patients with squamous cell carcinoma of the head and neck and nine patients with squamous cell carcinoma of the lung, whose tumours expressed EGFR, were recruited. Groups of three patients were treated with 2.5 mg, 10 mg, 20 mg or 40 mg of ICR62 and a further eight patients received 100 mg. All patients were evaluated for toxicity using WHO criteria. Patients' sera were tested for the clearance of MAb ICR62 and the development of human anti-rat antibodies (HARA). No serious (WHO Grade III-IV) toxicity was observed in patients treated with up to 100 mg of antibody ICR62. Antibody ICR62 could be detected at 4 h and 24 h in the sera of patients treated with 40 mg or 100 mg of ICR62. Only 4/20 patients showed HARA responses (one at 20 mg, one at 40 mg and two at 100 mg doses) and of these only the former two were anti-idiotypic responses. In four patients receiving doses of ICR62 at 40 mg or greater, biopsies were obtained from metastatic lesions 24 h later and examined for the localisation of ICR62 using anti-rat antibody reagent. In these patients we showed the localisation of MAb ICR62 to the membranes of tumour cells; this appeared to be more prominent at the higher dose of 100 mg. On the basis of these data we conclude that MAb ICR62 can be administered safely to patients with squamous cell carcinomas and that it can localise efficiently to metastases even at relatively low doses. More... »

PAGES

bjc199640

Journal

TITLE

British Journal of Cancer

ISSUE

2

VOLUME

73

Author Affiliations

Related Patents

  • Methods Of Generating Variant Proteins With Increased Host String Content
  • Combination Therapy With Mdm2 And Efgr Inhibitors
  • Treatment Method Using Egfr Antibodies And Src Inhibitors And Related Formulations
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Fc Variants With Increased Affinity For Fcγriic
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Fc Variants With Altered Binding To Fcrn
  • Dual Specific Binding Proteins Directed Against Il-1 And/Or Il-17
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Heterodimeric Antibodies To Cd3 X Cd123
  • Anti-Dll4/Vegf Dual Variable Domain Immunoglobulin And Uses Thereof
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Heterodimeric Proteins
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Specific Binding Proteins And Uses Thereof
  • Anti-Dll4/Vegf Dual Variable Domain Immunoglobulin And Uses Thereof
  • Il-1 Binding Proteins
  • Rapid Clearance Of Antigen Complexes Using Novel Antibodies
  • Antibodies With Modified Isoelectric Points
  • Il-1 Binding Proteins
  • Compositions And Methods For Simultaneous Bivalent And Monovalent Co-Engagement Of Antigens
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Fc Variants Having Increased Affinity For Fcyrllc
  • Methods And Compositions Of Targeted Drug Development
  • Fc Variants That Extend Antibody Half-Life
  • Fc Variants With Altered Binding To Fcrn
  • Anti-Dll4/Vegf Dual Variable Domain Immunoglobulin And Uses Thereof
  • Heterodimeric Proteins
  • Use Of Anti-Egfr Antibodies In Treatment Of Egfr Mutant Mediated Disease
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Fc Variants With Altered Binding To Fcrn
  • Pharmaceutical Composition Of Oxidised Avidin Suitable For Inhalation
  • Il-1 Binding Proteins
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Specific Binding Proteins And Uses Thereof
  • Antibodies Against Platelet-Derived Growth Factor (Pdgf)
  • Fc Variants With Altered Binding To Fcrn
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Methods Of Generating Variant Antibodies With Increased Host String Content
  • Fc Variants With Altered Binding To Fcrn
  • Fc Variants With Altered Binding To Fcrn
  • Combination Therapy With Mdm2 And Efgr Inhibitors
  • Il-1 Binding Proteins
  • Il-1 Binding Proteins
  • Combination Therapy With Mdm2 And Efgr Inhibitors
  • Prognostic Protocol
  • Prognostic Protocol
  • Heterodimeric Proteins
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Il-17 Binding Proteins
  • Il-17 Binding Proteins
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Fc Variants With Altered Binding To Fcrn
  • Anti-C-Met Tandem Fc Bispecific Antibodies
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Fc Variants
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Methods Of Targeted Drug Development
  • Il-17 Binding Proteins
  • Heterodimeric Antibodies To Cd3 X Cd20
  • Optimized Fc Variants And Methods For Their Generation
  • Dual Variable Domain Immunoglobulin And Uses Thereof
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Immunoglobulin Insertions, Deletions And Substitutions
  • Fc Variants With Altered Binding To Fcrn
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Pharmaceutical Composition Of Oxidised Avidin Suitable For Inhalation
  • Il-1 Binding Proteins
  • Prostaglandin E2 Dual Variable Domain Immunoglobulins And Uses Thereof
  • Il-I Binding Proteins
  • Monoclonal Antibody 175 Targeting The Egf Receptor And Derivatives And Uses Thereof
  • Fc Variants With Altered Binding To Fcrn
  • Dual Specific Binding Proteins Directed Against Il-1Β And/Or Il-17
  • Modified Fc Molecules
  • Bispecific Antibodies That Bind To Cd38 And Cd3
  • Dual Specific Binding Proteins Directed Against Il-13 And Il-17
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Il-1 Binding Proteins
  • Optimized Fc Variants And Methods For Their Generation
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Il-17 Binding Proteins
  • Il-17 Binding Proteins
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/bjc.1996.40

    DOI

    http://dx.doi.org/10.1038/bjc.1996.40

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1044564770

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/8546911


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Heterophile", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Carcinoma, Squamous Cell", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Membrane", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "ErbB Receptors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Head and Neck Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunotherapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lung Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Metastasis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Institute of Cancer Research", 
              "id": "https://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Section of Immunology, McElwain Laboratories, Institute of Cancer Research, Sutton, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Modjtahedi", 
            "givenName": "H", 
            "id": "sg:person.01056410041.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056410041.13"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Hickish", 
            "givenName": "T", 
            "id": "sg:person.01001206473.87", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001206473.87"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Nicolson", 
            "givenName": "M", 
            "id": "sg:person.01203740575.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203740575.36"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Moore", 
            "givenName": "J", 
            "id": "sg:person.01076364060.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076364060.22"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Styles", 
            "givenName": "J", 
            "id": "sg:person.01200253670.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200253670.41"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Eccles", 
            "givenName": "S", 
            "id": "sg:person.016313524317.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016313524317.09"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Jackson", 
            "givenName": "E", 
            "id": "sg:person.01034100673.40", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034100673.40"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Salter", 
            "givenName": "J", 
            "id": "sg:person.01221345036.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221345036.05"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Sloane", 
            "givenName": "J", 
            "id": "sg:person.01205560342.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205560342.38"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Spencer", 
            "givenName": "L", 
            "id": "sg:person.01030346240.80", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030346240.80"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Priest", 
            "givenName": "K", 
            "id": "sg:person.0762233040.78", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762233040.78"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Smith", 
            "givenName": "I", 
            "id": "sg:person.016301514162.37", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016301514162.37"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Dean", 
            "givenName": "C", 
            "id": "sg:person.0637732460.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637732460.22"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Gore", 
            "givenName": "M", 
            "id": "sg:person.012024134677.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012024134677.17"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1016/0092-8674(91)90638-f", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000209472"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1006/excr.1993.1022", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003291866"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/264026a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008395587", 
              "https://doi.org/10.1038/264026a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/264026a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008395587", 
              "https://doi.org/10.1038/264026a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/313745a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010441557", 
              "https://doi.org/10.1038/313745a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/path.1711490104", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010503247"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/path.1711490104", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010503247"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00666176", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011164383", 
              "https://doi.org/10.1007/bf00666176"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00666176", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011164383", 
              "https://doi.org/10.1007/bf00666176"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/1097-0142(19900401)65:7<1619::aid-cncr2820650728>3.0.co;2-q", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011677344"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1993.49", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013696546", 
              "https://doi.org/10.1038/bjc.1993.49"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1993.49", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013696546", 
              "https://doi.org/10.1038/bjc.1993.49"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/1097-0142(19940201)73:3+<884::aid-cncr2820731320>3.0.co;2-u", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014489761"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.8456283", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017259866"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/path.1711690204", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017770433"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/path.1711690204", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017770433"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/ijc.2910570722", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021879932"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0065-230x(08)60289-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031503264"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1993.48", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037345733", 
              "https://doi.org/10.1038/bjc.1993.48"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1993.48", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037345733", 
              "https://doi.org/10.1038/bjc.1993.48"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0360-3016(92)91009-c", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040457208"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(94)92398-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041139747"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(94)92398-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041139747"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1146/annurev.bi.56.070187.004313", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042809501"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/hed.2890090608", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044874590"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1006/bbrc.1995.1200", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051855424"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.74.7.2790", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052142572"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00666188", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053043589", 
              "https://doi.org/10.1007/bf00666188"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00666188", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053043589", 
              "https://doi.org/10.1007/bf00666188"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/jnci/83.2.97", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1059816806"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.1659742", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062497986"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.1840698", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062509886"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.2466334", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062538899"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3892/ijo.4.2.277", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1071516936"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1076087236", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/oxfordjournals.bmb.a072464", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1077677559"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1078055091", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1079375312", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1079411791", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1079502043", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1082668261", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.1994.12.4.730", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1082675068"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1996-01", 
        "datePublishedReg": "1996-01-01", 
        "description": "The purpose of this study was to determine the effect of the first rat monoclonal antibody (MAb ICR62) to the epidermal growth factor receptor (EGFR) in a phase I clinical trial in patients with unresectable squamous cell carcinomas. This antibody effectively blocks the binding of EGF, transforming growth factor (TGF)-alpha and HB-EGF to the EGFR, inhibits the growth in vitro of tumour cell lines which overexpress the EGFR and eradicates such tumours when grown as xenografts in athymic mice. Eleven patients with squamous cell carcinoma of the head and neck and nine patients with squamous cell carcinoma of the lung, whose tumours expressed EGFR, were recruited. Groups of three patients were treated with 2.5 mg, 10 mg, 20 mg or 40 mg of ICR62 and a further eight patients received 100 mg. All patients were evaluated for toxicity using WHO criteria. Patients' sera were tested for the clearance of MAb ICR62 and the development of human anti-rat antibodies (HARA). No serious (WHO Grade III-IV) toxicity was observed in patients treated with up to 100 mg of antibody ICR62. Antibody ICR62 could be detected at 4 h and 24 h in the sera of patients treated with 40 mg or 100 mg of ICR62. Only 4/20 patients showed HARA responses (one at 20 mg, one at 40 mg and two at 100 mg doses) and of these only the former two were anti-idiotypic responses. In four patients receiving doses of ICR62 at 40 mg or greater, biopsies were obtained from metastatic lesions 24 h later and examined for the localisation of ICR62 using anti-rat antibody reagent. In these patients we showed the localisation of MAb ICR62 to the membranes of tumour cells; this appeared to be more prominent at the higher dose of 100 mg. On the basis of these data we conclude that MAb ICR62 can be administered safely to patients with squamous cell carcinomas and that it can localise efficiently to metastases even at relatively low doses.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/bjc.1996.40", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1017082", 
            "issn": [
              "0007-0920", 
              "1532-1827"
            ], 
            "name": "British Journal of Cancer", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "73"
          }
        ], 
        "name": "Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer", 
        "pagination": "bjc199640", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "d446dc4c4fa647233a2a2d2323c9fa480ac743d094eec221b91a6e3a3b2ea960"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "8546911"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0370635"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/bjc.1996.40"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1044564770"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/bjc.1996.40", 
          "https://app.dimensions.ai/details/publication/pub.1044564770"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T11:53", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29194_00000002.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://www.nature.com/articles/bjc199640"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1996.40'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1996.40'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1996.40'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1996.40'


     

    This table displays all metadata directly associated to this object as RDF triples.

    317 TRIPLES      21 PREDICATES      80 URIs      38 LITERALS      26 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/bjc.1996.40 schema:about N0ae5b338f3e3421982218f8c59a51ca9
    2 N0aee486c806841ebbb15d8cfc19b204d
    3 N2cc43e57dceb4621b1fb8d8cbb799496
    4 N34e4845220034988bc73e5a340368194
    5 N49110f31ba6547b9a72e1c47ccaefef0
    6 N5dce654480bc4335817e07550bae7f22
    7 N6e02fb61acbb47aa9542003f4b625e80
    8 N6fefef6a132845e5a355037cb2b61d91
    9 N749e2dcddd3e40f2b01f1c039fb523ce
    10 N822a6290abbd46bebe414d98f1f6aba1
    11 N95e6a8a16a824694b4e2ef30e6789ebf
    12 N9ee200cd14b341df8405c652bac91b2a
    13 Na814cfa6ce8b4d52b41b57a7e06dc325
    14 Na8a7bc83e080488a86a4815ad9831342
    15 Nba1a0faf5f5c4cfd9e14d3539fc27423
    16 Ne970b9cc2a3f441d9204432731e9a417
    17 Nf1eae3b3356e4152a4f664983a5b7986
    18 anzsrc-for:11
    19 anzsrc-for:1112
    20 schema:author Ndd235bd13c1b4257a92d8526fc7069e9
    21 schema:citation sg:pub.10.1007/bf00666176
    22 sg:pub.10.1007/bf00666188
    23 sg:pub.10.1038/264026a0
    24 sg:pub.10.1038/313745a0
    25 sg:pub.10.1038/bjc.1993.48
    26 sg:pub.10.1038/bjc.1993.49
    27 https://app.dimensions.ai/details/publication/pub.1076087236
    28 https://app.dimensions.ai/details/publication/pub.1078055091
    29 https://app.dimensions.ai/details/publication/pub.1079375312
    30 https://app.dimensions.ai/details/publication/pub.1079411791
    31 https://app.dimensions.ai/details/publication/pub.1079502043
    32 https://app.dimensions.ai/details/publication/pub.1082668261
    33 https://doi.org/10.1002/1097-0142(19900401)65:7<1619::aid-cncr2820650728>3.0.co;2-q
    34 https://doi.org/10.1002/1097-0142(19940201)73:3+<884::aid-cncr2820731320>3.0.co;2-u
    35 https://doi.org/10.1002/hed.2890090608
    36 https://doi.org/10.1002/ijc.2910570722
    37 https://doi.org/10.1002/path.1711490104
    38 https://doi.org/10.1002/path.1711690204
    39 https://doi.org/10.1006/bbrc.1995.1200
    40 https://doi.org/10.1006/excr.1993.1022
    41 https://doi.org/10.1016/0092-8674(91)90638-f
    42 https://doi.org/10.1016/0360-3016(92)91009-c
    43 https://doi.org/10.1016/s0065-230x(08)60289-4
    44 https://doi.org/10.1016/s0140-6736(94)92398-1
    45 https://doi.org/10.1073/pnas.74.7.2790
    46 https://doi.org/10.1093/jnci/83.2.97
    47 https://doi.org/10.1093/oxfordjournals.bmb.a072464
    48 https://doi.org/10.1126/science.1659742
    49 https://doi.org/10.1126/science.1840698
    50 https://doi.org/10.1126/science.2466334
    51 https://doi.org/10.1126/science.8456283
    52 https://doi.org/10.1146/annurev.bi.56.070187.004313
    53 https://doi.org/10.1200/jco.1994.12.4.730
    54 https://doi.org/10.3892/ijo.4.2.277
    55 schema:datePublished 1996-01
    56 schema:datePublishedReg 1996-01-01
    57 schema:description The purpose of this study was to determine the effect of the first rat monoclonal antibody (MAb ICR62) to the epidermal growth factor receptor (EGFR) in a phase I clinical trial in patients with unresectable squamous cell carcinomas. This antibody effectively blocks the binding of EGF, transforming growth factor (TGF)-alpha and HB-EGF to the EGFR, inhibits the growth in vitro of tumour cell lines which overexpress the EGFR and eradicates such tumours when grown as xenografts in athymic mice. Eleven patients with squamous cell carcinoma of the head and neck and nine patients with squamous cell carcinoma of the lung, whose tumours expressed EGFR, were recruited. Groups of three patients were treated with 2.5 mg, 10 mg, 20 mg or 40 mg of ICR62 and a further eight patients received 100 mg. All patients were evaluated for toxicity using WHO criteria. Patients' sera were tested for the clearance of MAb ICR62 and the development of human anti-rat antibodies (HARA). No serious (WHO Grade III-IV) toxicity was observed in patients treated with up to 100 mg of antibody ICR62. Antibody ICR62 could be detected at 4 h and 24 h in the sera of patients treated with 40 mg or 100 mg of ICR62. Only 4/20 patients showed HARA responses (one at 20 mg, one at 40 mg and two at 100 mg doses) and of these only the former two were anti-idiotypic responses. In four patients receiving doses of ICR62 at 40 mg or greater, biopsies were obtained from metastatic lesions 24 h later and examined for the localisation of ICR62 using anti-rat antibody reagent. In these patients we showed the localisation of MAb ICR62 to the membranes of tumour cells; this appeared to be more prominent at the higher dose of 100 mg. On the basis of these data we conclude that MAb ICR62 can be administered safely to patients with squamous cell carcinomas and that it can localise efficiently to metastases even at relatively low doses.
    58 schema:genre research_article
    59 schema:inLanguage en
    60 schema:isAccessibleForFree true
    61 schema:isPartOf N0c2bfa192b3243cc951cee8ff0ae675f
    62 Ned840451e42f416d80b8330f9781084a
    63 sg:journal.1017082
    64 schema:name Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer
    65 schema:pagination bjc199640
    66 schema:productId N1f27059ca00e48a8b840a63edb4e50ce
    67 N5332f4dc1358447dbff069c1293af518
    68 N945dc531be194c9fa97fedb9604f0f63
    69 Nd05bdeb4506542a3915864e13c1b4a81
    70 Ne025be4a5a604ff5bdc72076f0f5b8f1
    71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044564770
    72 https://doi.org/10.1038/bjc.1996.40
    73 schema:sdDatePublished 2019-04-11T11:53
    74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    75 schema:sdPublisher N34fe0cb96c044474904947e40b92ff61
    76 schema:url http://www.nature.com/articles/bjc199640
    77 sgo:license sg:explorer/license/
    78 sgo:sdDataset articles
    79 rdf:type schema:ScholarlyArticle
    80 N07cce9f02a13409eb6af8aae834aa550 rdf:first sg:person.01203740575.36
    81 rdf:rest Nd2981f92e04e4897b96d981b328879c8
    82 N0ae5b338f3e3421982218f8c59a51ca9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    83 schema:name Head and Neck Neoplasms
    84 rdf:type schema:DefinedTerm
    85 N0aee486c806841ebbb15d8cfc19b204d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    86 schema:name Adult
    87 rdf:type schema:DefinedTerm
    88 N0b7231ec304d4d33a42fc88eb85af377 rdf:first sg:person.01205560342.38
    89 rdf:rest Ndf7327b84b724f37bc0d559de9bca103
    90 N0c2bfa192b3243cc951cee8ff0ae675f schema:volumeNumber 73
    91 rdf:type schema:PublicationVolume
    92 N1f27059ca00e48a8b840a63edb4e50ce schema:name pubmed_id
    93 schema:value 8546911
    94 rdf:type schema:PropertyValue
    95 N2cc43e57dceb4621b1fb8d8cbb799496 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    96 schema:name ErbB Receptors
    97 rdf:type schema:DefinedTerm
    98 N34e4845220034988bc73e5a340368194 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    99 schema:name Lung Neoplasms
    100 rdf:type schema:DefinedTerm
    101 N34fe0cb96c044474904947e40b92ff61 schema:name Springer Nature - SN SciGraph project
    102 rdf:type schema:Organization
    103 N49110f31ba6547b9a72e1c47ccaefef0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    104 schema:name Humans
    105 rdf:type schema:DefinedTerm
    106 N5332f4dc1358447dbff069c1293af518 schema:name nlm_unique_id
    107 schema:value 0370635
    108 rdf:type schema:PropertyValue
    109 N5dce654480bc4335817e07550bae7f22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Cell Membrane
    111 rdf:type schema:DefinedTerm
    112 N64e798f2d2ef4eb3b0502a62978dfdbc rdf:first sg:person.0762233040.78
    113 rdf:rest Ne2671c39d7e447208b1ef699115e2afd
    114 N6cd62f1ad0f945fdbf42fbcd8f384fe8 rdf:first sg:person.01001206473.87
    115 rdf:rest N07cce9f02a13409eb6af8aae834aa550
    116 N6e02fb61acbb47aa9542003f4b625e80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    117 schema:name Male
    118 rdf:type schema:DefinedTerm
    119 N6e8db1956f0b4bd48b2de4aa74ed7ec5 rdf:first sg:person.01221345036.05
    120 rdf:rest N0b7231ec304d4d33a42fc88eb85af377
    121 N6fefef6a132845e5a355037cb2b61d91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Rats
    123 rdf:type schema:DefinedTerm
    124 N749e2dcddd3e40f2b01f1c039fb523ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Animals
    126 rdf:type schema:DefinedTerm
    127 N822a6290abbd46bebe414d98f1f6aba1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Middle Aged
    129 rdf:type schema:DefinedTerm
    130 N945dc531be194c9fa97fedb9604f0f63 schema:name doi
    131 schema:value 10.1038/bjc.1996.40
    132 rdf:type schema:PropertyValue
    133 N95e6a8a16a824694b4e2ef30e6789ebf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Carcinoma, Squamous Cell
    135 rdf:type schema:DefinedTerm
    136 N9a0c092d6d0c41ef85e505d5f911a99c rdf:first sg:person.0637732460.22
    137 rdf:rest N9dc98278d76d4ffc8aa87a0e2ca86df5
    138 N9dc98278d76d4ffc8aa87a0e2ca86df5 rdf:first sg:person.012024134677.17
    139 rdf:rest rdf:nil
    140 N9ee200cd14b341df8405c652bac91b2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Antibodies, Monoclonal
    142 rdf:type schema:DefinedTerm
    143 Na814cfa6ce8b4d52b41b57a7e06dc325 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Aged
    145 rdf:type schema:DefinedTerm
    146 Na8a7bc83e080488a86a4815ad9831342 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Female
    148 rdf:type schema:DefinedTerm
    149 Naffe62976ba6422abb543133ff33ecd1 rdf:first sg:person.01200253670.41
    150 rdf:rest Nf7a2d20f4ed545db8fe396edbb358593
    151 Nba1a0faf5f5c4cfd9e14d3539fc27423 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Immunotherapy
    153 rdf:type schema:DefinedTerm
    154 Nd05bdeb4506542a3915864e13c1b4a81 schema:name readcube_id
    155 schema:value d446dc4c4fa647233a2a2d2323c9fa480ac743d094eec221b91a6e3a3b2ea960
    156 rdf:type schema:PropertyValue
    157 Nd1e06167cdfe472e8cc46ef0a0e48665 rdf:first sg:person.01034100673.40
    158 rdf:rest N6e8db1956f0b4bd48b2de4aa74ed7ec5
    159 Nd2981f92e04e4897b96d981b328879c8 rdf:first sg:person.01076364060.22
    160 rdf:rest Naffe62976ba6422abb543133ff33ecd1
    161 Ndd235bd13c1b4257a92d8526fc7069e9 rdf:first sg:person.01056410041.13
    162 rdf:rest N6cd62f1ad0f945fdbf42fbcd8f384fe8
    163 Ndf7327b84b724f37bc0d559de9bca103 rdf:first sg:person.01030346240.80
    164 rdf:rest N64e798f2d2ef4eb3b0502a62978dfdbc
    165 Ne025be4a5a604ff5bdc72076f0f5b8f1 schema:name dimensions_id
    166 schema:value pub.1044564770
    167 rdf:type schema:PropertyValue
    168 Ne2671c39d7e447208b1ef699115e2afd rdf:first sg:person.016301514162.37
    169 rdf:rest N9a0c092d6d0c41ef85e505d5f911a99c
    170 Ne970b9cc2a3f441d9204432731e9a417 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Antibodies, Heterophile
    172 rdf:type schema:DefinedTerm
    173 Ned840451e42f416d80b8330f9781084a schema:issueNumber 2
    174 rdf:type schema:PublicationIssue
    175 Nf1eae3b3356e4152a4f664983a5b7986 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Neoplasm Metastasis
    177 rdf:type schema:DefinedTerm
    178 Nf7a2d20f4ed545db8fe396edbb358593 rdf:first sg:person.016313524317.09
    179 rdf:rest Nd1e06167cdfe472e8cc46ef0a0e48665
    180 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    181 schema:name Medical and Health Sciences
    182 rdf:type schema:DefinedTerm
    183 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    184 schema:name Oncology and Carcinogenesis
    185 rdf:type schema:DefinedTerm
    186 sg:journal.1017082 schema:issn 0007-0920
    187 1532-1827
    188 schema:name British Journal of Cancer
    189 rdf:type schema:Periodical
    190 sg:person.01001206473.87 schema:familyName Hickish
    191 schema:givenName T
    192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001206473.87
    193 rdf:type schema:Person
    194 sg:person.01030346240.80 schema:familyName Spencer
    195 schema:givenName L
    196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030346240.80
    197 rdf:type schema:Person
    198 sg:person.01034100673.40 schema:familyName Jackson
    199 schema:givenName E
    200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034100673.40
    201 rdf:type schema:Person
    202 sg:person.01056410041.13 schema:affiliation https://www.grid.ac/institutes/grid.18886.3f
    203 schema:familyName Modjtahedi
    204 schema:givenName H
    205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056410041.13
    206 rdf:type schema:Person
    207 sg:person.01076364060.22 schema:familyName Moore
    208 schema:givenName J
    209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076364060.22
    210 rdf:type schema:Person
    211 sg:person.01200253670.41 schema:familyName Styles
    212 schema:givenName J
    213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200253670.41
    214 rdf:type schema:Person
    215 sg:person.012024134677.17 schema:familyName Gore
    216 schema:givenName M
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012024134677.17
    218 rdf:type schema:Person
    219 sg:person.01203740575.36 schema:familyName Nicolson
    220 schema:givenName M
    221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203740575.36
    222 rdf:type schema:Person
    223 sg:person.01205560342.38 schema:familyName Sloane
    224 schema:givenName J
    225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205560342.38
    226 rdf:type schema:Person
    227 sg:person.01221345036.05 schema:familyName Salter
    228 schema:givenName J
    229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221345036.05
    230 rdf:type schema:Person
    231 sg:person.016301514162.37 schema:familyName Smith
    232 schema:givenName I
    233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016301514162.37
    234 rdf:type schema:Person
    235 sg:person.016313524317.09 schema:familyName Eccles
    236 schema:givenName S
    237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016313524317.09
    238 rdf:type schema:Person
    239 sg:person.0637732460.22 schema:familyName Dean
    240 schema:givenName C
    241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637732460.22
    242 rdf:type schema:Person
    243 sg:person.0762233040.78 schema:familyName Priest
    244 schema:givenName K
    245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762233040.78
    246 rdf:type schema:Person
    247 sg:pub.10.1007/bf00666176 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011164383
    248 https://doi.org/10.1007/bf00666176
    249 rdf:type schema:CreativeWork
    250 sg:pub.10.1007/bf00666188 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053043589
    251 https://doi.org/10.1007/bf00666188
    252 rdf:type schema:CreativeWork
    253 sg:pub.10.1038/264026a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008395587
    254 https://doi.org/10.1038/264026a0
    255 rdf:type schema:CreativeWork
    256 sg:pub.10.1038/313745a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010441557
    257 https://doi.org/10.1038/313745a0
    258 rdf:type schema:CreativeWork
    259 sg:pub.10.1038/bjc.1993.48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037345733
    260 https://doi.org/10.1038/bjc.1993.48
    261 rdf:type schema:CreativeWork
    262 sg:pub.10.1038/bjc.1993.49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013696546
    263 https://doi.org/10.1038/bjc.1993.49
    264 rdf:type schema:CreativeWork
    265 https://app.dimensions.ai/details/publication/pub.1076087236 schema:CreativeWork
    266 https://app.dimensions.ai/details/publication/pub.1078055091 schema:CreativeWork
    267 https://app.dimensions.ai/details/publication/pub.1079375312 schema:CreativeWork
    268 https://app.dimensions.ai/details/publication/pub.1079411791 schema:CreativeWork
    269 https://app.dimensions.ai/details/publication/pub.1079502043 schema:CreativeWork
    270 https://app.dimensions.ai/details/publication/pub.1082668261 schema:CreativeWork
    271 https://doi.org/10.1002/1097-0142(19900401)65:7<1619::aid-cncr2820650728>3.0.co;2-q schema:sameAs https://app.dimensions.ai/details/publication/pub.1011677344
    272 rdf:type schema:CreativeWork
    273 https://doi.org/10.1002/1097-0142(19940201)73:3+<884::aid-cncr2820731320>3.0.co;2-u schema:sameAs https://app.dimensions.ai/details/publication/pub.1014489761
    274 rdf:type schema:CreativeWork
    275 https://doi.org/10.1002/hed.2890090608 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044874590
    276 rdf:type schema:CreativeWork
    277 https://doi.org/10.1002/ijc.2910570722 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021879932
    278 rdf:type schema:CreativeWork
    279 https://doi.org/10.1002/path.1711490104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010503247
    280 rdf:type schema:CreativeWork
    281 https://doi.org/10.1002/path.1711690204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017770433
    282 rdf:type schema:CreativeWork
    283 https://doi.org/10.1006/bbrc.1995.1200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051855424
    284 rdf:type schema:CreativeWork
    285 https://doi.org/10.1006/excr.1993.1022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003291866
    286 rdf:type schema:CreativeWork
    287 https://doi.org/10.1016/0092-8674(91)90638-f schema:sameAs https://app.dimensions.ai/details/publication/pub.1000209472
    288 rdf:type schema:CreativeWork
    289 https://doi.org/10.1016/0360-3016(92)91009-c schema:sameAs https://app.dimensions.ai/details/publication/pub.1040457208
    290 rdf:type schema:CreativeWork
    291 https://doi.org/10.1016/s0065-230x(08)60289-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031503264
    292 rdf:type schema:CreativeWork
    293 https://doi.org/10.1016/s0140-6736(94)92398-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041139747
    294 rdf:type schema:CreativeWork
    295 https://doi.org/10.1073/pnas.74.7.2790 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052142572
    296 rdf:type schema:CreativeWork
    297 https://doi.org/10.1093/jnci/83.2.97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059816806
    298 rdf:type schema:CreativeWork
    299 https://doi.org/10.1093/oxfordjournals.bmb.a072464 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077677559
    300 rdf:type schema:CreativeWork
    301 https://doi.org/10.1126/science.1659742 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062497986
    302 rdf:type schema:CreativeWork
    303 https://doi.org/10.1126/science.1840698 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062509886
    304 rdf:type schema:CreativeWork
    305 https://doi.org/10.1126/science.2466334 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062538899
    306 rdf:type schema:CreativeWork
    307 https://doi.org/10.1126/science.8456283 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017259866
    308 rdf:type schema:CreativeWork
    309 https://doi.org/10.1146/annurev.bi.56.070187.004313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042809501
    310 rdf:type schema:CreativeWork
    311 https://doi.org/10.1200/jco.1994.12.4.730 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082675068
    312 rdf:type schema:CreativeWork
    313 https://doi.org/10.3892/ijo.4.2.277 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071516936
    314 rdf:type schema:CreativeWork
    315 https://www.grid.ac/institutes/grid.18886.3f schema:alternateName Institute of Cancer Research
    316 schema:name Section of Immunology, McElwain Laboratories, Institute of Cancer Research, Sutton, UK.
    317 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...